NCT00417027

Brief Summary

Studies suggest that administration of maintenance epidural solutions as programmed or automated intermittent boluses, rather than continuous infusions, result in lower bupivacaine consumption, decreased need for manual boluses by the anesthesiologist, and greater patient satisfaction. In this technique, the epidural maintenance dose is administered as a bolus by the infusion pump at regular intervals instead of as a continuous infusion. However, the optimal combination of bolus volume and dosing interval has not been determined. At one end of the spectrum, a small volume and short bolus dose interval will likely behave like a continuous infusion. At the other end of the spectrum, a large volume and long bolus dose interval may lead to an increased incidence of breakthrough pain. The purpose of this randomized, double-blind trial was to determine how manipulation of the programmed intermittent time interval and volume influences total drug use, quality of analgesia, and patient satisfaction during maintenance of labor analgesia. We hypothesized that manipulation of the programmed intermittent bolus time interval and volume during the maintenance of epidural labor analgesia influences total drug use, quality of analgesia and patient satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
190

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 28, 2006

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

December 9, 2011

Completed
Last Updated

April 14, 2014

Status Verified

March 1, 2014

Enrollment Period

2.6 years

First QC Date

December 27, 2006

Results QC Date

June 28, 2011

Last Update Submit

March 17, 2014

Conditions

Keywords

Patient controlled epidural analgesiaLabor analgesiaEpidural analgesia

Outcome Measures

Primary Outcomes (1)

  • Total Bupivicaine in Milligrams Administered Per Hour of Labor for Analgesia.

    Total bupivacaine from epidural solution administered for labor analgesia normalized per hour of labor.

    From initiation of labor analgesia until delivery less than 24 hours

Secondary Outcomes (6)

  • Area Under the Visual Analog Pain Scores (0 to 100mm) Per Hour of Labor Analgesia Curve

    Duration of labor analgesia

  • Patient Controlled Bolus Attempts

    Duration of labor analgesia

  • Number of Patient Controlled Bolus Doses of Bupivacaine/Fentanyl Administered

    Duration of labor analgesia

  • Manual Bolus Doses Administered

    Duration of labor analgesia

  • Highest Thoracic Dermatome Sensory Level to Ice. Higher Levels Are Given by Lower Thoracic Vertebral Number.

    3 hours after initiation of labor analgesia

  • +1 more secondary outcomes

Study Arms (3)

2.5 mL bolused every 15 minutes

ACTIVE COMPARATOR
Procedure: Programmed Intermittent Epidural Bolus (PIEB)

5ml bolused every 30 minutes

ACTIVE COMPARATOR
Procedure: Programmed Intermittent Epidural Bolus (PIEB)

10ml bolused every 60 minutes

ACTIVE COMPARATOR
Procedure: Programmed Intermittent Epidural Bolus (PIEB)

Interventions

A commercial pump that can be programmed to administer intermittent boluses and patient controlled boluses does not exist. Two pumps were prepared for each subject with the same epidural solution. One pump was programmed to administer the programmed intermittent epidural bolus(PIEB). The second pump was programmed to administer patient controlled epidural analgesia (PCEA)with a dose of 5 mL delivered with a lockout of every 10 minutes.

Also known as: Hospira Gemstar infusion pump
10ml bolused every 60 minutes2.5 mL bolused every 15 minutes5ml bolused every 30 minutes

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • nulliparous women
  • term gestation (greater than or equal to 37 weeks gestation)
  • spontaneous labor or with spontaneous rupture of membranes

You may not qualify if:

  • Systemic disease (e.g., diabetes mellitus, hypertension, preeclampsia)
  • use of chronic analgesic medications
  • systemic opioid labor analgesia prior to the initiation of neuraxial labor analgesia
  • cervical dilation less than 2cm or greater than 5cm at time of initiation of neuraxial analgesia
  • delivery within 90 minutes of intrathecal injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location

Related Publications (17)

  • Paech MJ, Pavy TJ, Sims C, Westmore MD, Storey JM, White C. Clinical experience with patient-controlled and staff-administered intermittent bolus epidural analgesia in labour. Anaesth Intensive Care. 1995 Aug;23(4):459-63. doi: 10.1177/0310057X9502300408.

    PMID: 7485937BACKGROUND
  • Boutros A, Blary S, Bronchard R, Bonnet F. Comparison of intermittent epidural bolus, continuous epidural infusion and patient controlled-epidural analgesia during labor. Int J Obstet Anesth. 1999 Oct;8(4):236-41. doi: 10.1016/s0959-289x(99)80103-4.

    PMID: 15321117BACKGROUND
  • Bogod DG, Rosen M, Rees GA. Extradural infusion of 0.125% bupivacaine at 10 ml h-1 to women during labour. Br J Anaesth. 1987 Mar;59(3):325-30. doi: 10.1093/bja/59.3.325.

    PMID: 3828182BACKGROUND
  • Smedstad KG, Morison DH. A comparative study of continuous and intermittent epidural analgesia for labour and delivery. Can J Anaesth. 1988 May;35(3 ( Pt 1)):234-41. doi: 10.1007/BF03010616.

    PMID: 3289768BACKGROUND
  • van der Vyver M, Halpern S, Joseph G. Patient-controlled epidural analgesia versus continuous infusion for labour analgesia: a meta-analysis. Br J Anaesth. 2002 Sep;89(3):459-65. doi: 10.1093/bja/aef217.

    PMID: 12402726BACKGROUND
  • Paech MJ. Patient-controlled epidural analgesia in labour--is a continuous infusion of benefit? Anaesth Intensive Care. 1992 Feb;20(1):15-20. doi: 10.1177/0310057X9202000103.

    PMID: 1609935BACKGROUND
  • Ferrante FM, Rosinia FA, Gordon C, Datta S. The role of continuous background infusions in patient-controlled epidural analgesia for labor and delivery. Anesth Analg. 1994 Jul;79(1):80-4. doi: 10.1213/00000539-199407000-00015.

    PMID: 8010458BACKGROUND
  • Boselli E, Debon R, Cimino Y, Rimmele T, Allaouchiche B, Chassard D. Background infusion is not beneficial during labor patient-controlled analgesia with 0.1% ropivacaine plus 0.5 microg/ml sufentanil. Anesthesiology. 2004 Apr;100(4):968-72. doi: 10.1097/00000542-200404000-00030.

    PMID: 15087635BACKGROUND
  • Petry J, Vercauteren M, Van Mol I, Van Houwe P, Adriaensen HA. Epidural PCA with bupivacaine 0.125%, sufentanil 0.75 microgram and epinephrine 1/800.000 for labor analgesia: is a background infusion beneficial? Acta Anaesthesiol Belg. 2000;51(3):163-6.

    PMID: 11129615BACKGROUND
  • Halonen P, Sarvela J, Saisto T, Soikkeli A, Halmesmaki E, Korttila K. Patient-controlled epidural technique improves analgesia for labor but increases cesarean delivery rate compared with the intermittent bolus technique. Acta Anaesthesiol Scand. 2004 Jul;48(6):732-7. doi: 10.1111/j.0001-5172.2004.00413.x.

    PMID: 15196106BACKGROUND
  • Chua SM, Sia AT. Automated intermittent epidural boluses improve analgesia induced by intrathecal fentanyl during labour. Can J Anaesth. 2004 Jun-Jul;51(6):581-5. doi: 10.1007/BF03018402.

    PMID: 15197122BACKGROUND
  • Ueda K, Ueda W, Manabe M. A comparative study of sequential epidural bolus technique and continuous epidural infusion. Anesthesiology. 2005 Jul;103(1):126-9. doi: 10.1097/00000542-200507000-00019.

    PMID: 15983464BACKGROUND
  • Hogan Q. Distribution of solution in the epidural space: examination by cryomicrotome section. Reg Anesth Pain Med. 2002 Mar-Apr;27(2):150-6. doi: 10.1053/rapm.2002.29748.

    PMID: 11915061BACKGROUND
  • Chestnut DH, Owen CL, Bates JN, Ostman LG, Choi WW, Geiger MW. Continuous infusion epidural analgesia during labor: a randomized, double-blind comparison of 0.0625% bupivacaine/0.0002% fentanyl versus 0.125% bupivacaine. Anesthesiology. 1988 May;68(5):754-9.

    PMID: 3285732BACKGROUND
  • Li DF, Rees GA, Rosen M. Continuous extradural infusion of 0.0625% or 0.125% bupivacaine for pain relief in primigravid labour. Br J Anaesth. 1985 Mar;57(3):264-70. doi: 10.1093/bja/57.3.264.

    PMID: 3978008BACKGROUND
  • Bernard JM, Le Roux D, Vizquel L, Barthe A, Gonnet JM, Aldebert A, Benani RM, Fossat C, Frouin J. Patient-controlled epidural analgesia during labor: the effects of the increase in bolus and lockout interval. Anesth Analg. 2000 Feb;90(2):328-32. doi: 10.1097/00000539-200002000-00017.

    PMID: 10648316BACKGROUND
  • Gambling DR, Huber CJ, Berkowitz J, Howell P, Swenerton JE, Ross PL, Crochetiere CT, Pavy TJ. Patient-controlled epidural analgesia in labour: varying bolus dose and lockout interval. Can J Anaesth. 1993 Mar;40(3):211-7. doi: 10.1007/BF03037032.

    PMID: 8467542BACKGROUND

MeSH Terms

Conditions

Labor Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

No group that received a continuous infusion or PCEA without a background infusion was included. Conclusions are limited to our patient population, drug concentrations, and mode of initiation of labor analgesia.

Results Point of Contact

Title
Robert J. McCarthy, PharmD
Organization
Northwestern University Feinberg School of Medicine

Study Officials

  • Cynthia A Wong, M.D.

    Northwestern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology

Study Record Dates

First Submitted

December 27, 2006

First Posted

December 28, 2006

Study Start

August 1, 2006

Primary Completion

March 1, 2009

Study Completion

April 1, 2009

Last Updated

April 14, 2014

Results First Posted

December 9, 2011

Record last verified: 2014-03

Locations